ArticleAfrican health sciences2025
Diagnostic value of the cardiophrenic lymph nodes in gastric peritoneum metastases.
Article in African health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The presence of cardiophrenic lymph nodes (CPLN) was potentially associated with peritoneal involvement in patients with abdominal malignancies. In this study, gastric cancer patients were investigated for the relationship between CPLN and peritoneum metastases. Methodology: Peritoneal exploration was performed on 516 gastric cancer patients between 2017 and 2019, including 134 (26%) with peritoneal metastases (PM). An univariate and multivariate analysis of preoperative computed tomography (CT) scans was conducted to assess the association between CPLN and confirmed PM. Results: Among the factors associated with CPLN in the univariate analysis, PM accounted for the strongest association (P < 0.001). In the multivariate analysis, PM was the only independent factor associated with CPLN (odds ratio [OR], 7.8; 95% confidence interval [CI], 4.6 ∼ 13.0; P < 0.001). CPLN was significantly more common in the 38 patients with classic signs of PM compared to the 96 patients without visible signs of PM (36/38 [95%] versus 76/96 [79%]). CT scan sensitivity rose from 28% (38/134 patients) to 85% (114/134 patients) with CPLN detection added to other diagnostic signs of PM. Conclusion: Detecting CPLN on CT was a valuable tool for diagnosing peritoneal metastases of gastric cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.